IDXX חוב כולל להון IDEXX Lab

IDEXX Laboratories, Inc. (IDXX) proprietary manufacturing plants ensure supply stability, which partially offsets the risks of declining consumer demand. The company's debt-to-equity ratio illustrates the dynamics of its financial recovery, while 0.73 determines the latest valuation metric. Monopoly ownership of analyzers in clinics guarantees a steady cash flow through the mandatory purchase of proprietary consumables.

A conservative investor views this ratio as a measure of financial stability. The ownership of proprietary plants and laboratories by IDEXX Laboratories, Inc. (IDXX) requires a balance between capital expenditures and borrowed funds. Analyzing the current total debt leverage, we compare total liabilities against the net asset value. A low value confirms solvency, while moderate debt optimizes profitability. A stable trend guarantees the long-term operational security of the business.